H. Eibl

936 total citations
34 papers, 712 citations indexed

About

H. Eibl is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Eibl has authored 34 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Eibl's work include Organophosphorus compounds synthesis (11 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (4 papers) and Fungal Plant Pathogen Control (3 papers). H. Eibl is often cited by papers focused on Organophosphorus compounds synthesis (11 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (4 papers) and Fungal Plant Pathogen Control (3 papers). H. Eibl collaborates with scholars based in Germany, Austria and Sweden. H. Eibl's co-authors include Karl Harlos, I. Pascher, S. Sundell, Clemens Unger, P. Hilgard, G. Hiller, K. Weber, Christine Unger, Bao Zhu Yu and Joe Rogers and has published in prestigious journals such as Biochemistry, Journal of Virology and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

H. Eibl

30 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Eibl Germany 13 479 132 91 86 56 34 712
Lech Dudycz United States 16 557 1.2× 203 1.5× 54 0.6× 91 1.1× 60 1.1× 34 755
Judith Rittenhouse United States 17 653 1.4× 152 1.2× 65 0.7× 68 0.8× 76 1.4× 24 1.2k
L. Pinteric Canada 17 755 1.6× 128 1.0× 85 0.9× 60 0.7× 94 1.7× 28 1.1k
Anthony J. Cocuzza United States 13 813 1.7× 359 2.7× 59 0.6× 45 0.5× 96 1.7× 19 1.4k
Hansruedi Kiefer United States 12 477 1.0× 116 0.9× 254 2.8× 51 0.6× 114 2.0× 14 1.2k
Gabriela Mustata United States 14 351 0.7× 102 0.8× 49 0.5× 82 1.0× 27 0.5× 17 592
Tavner J. Delcamp United States 17 611 1.3× 126 1.0× 47 0.5× 63 0.7× 42 0.8× 29 814
Priscilla P. Saunders United States 17 768 1.6× 121 0.9× 110 1.2× 154 1.8× 150 2.7× 38 1.1k
Pete Dunten United States 17 583 1.2× 127 1.0× 144 1.6× 53 0.6× 145 2.6× 31 902
D.K. Stammers United Kingdom 13 443 0.9× 87 0.7× 44 0.5× 96 1.1× 38 0.7× 14 652

Countries citing papers authored by H. Eibl

Since Specialization
Citations

This map shows the geographic impact of H. Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Eibl more than expected).

Fields of papers citing papers by H. Eibl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Eibl. The network helps show where H. Eibl may publish in the future.

Co-authorship network of co-authors of H. Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of H. Eibl. A scholar is included among the top collaborators of H. Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Eibl. H. Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkovic, Dinko, E. A. M. Fleer, H. Eibl, & Clemens Unger. (2015). Effects of Hexadecylphosphocholine on Cellular Function. Progress in tumor research. 34. 59–68.
2.
Unger, Christian, H. Sindermann, M. Peukert, et al.. (2015). Hexadecylphosphocholine in the Topical Treatment of Skin Metastases in Breast Cancer Patients. Progress in tumor research. 34. 153–159. 6 indexed citations
3.
Berger, Martin R., Martin Reinhardt, T. Klenner, et al.. (2015). Antitumor Activity of Alkylphosphocholines and Analogues in Methylnitrosourea-Induced Rat Mammary Carcinomas. Progress in tumor research. 34. 98–115. 3 indexed citations
4.
Fleer, E. A. M., Dinko Berkovic, Clemens Unger, & H. Eibl. (2015). Cellular Uptake and Metabolic Fate of Hexadecylphosphocholine. Progress in tumor research. 34. 33–46. 3 indexed citations
5.
Handrick, René, et al.. (2005). Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation. Biochemical Pharmacology. 70(6). 837–850. 10 indexed citations
6.
Walochnik, Julia, Michael Duchêne, H. Eibl, & Horst Aspöck. (2003). Treatment of Acanthamoeba keratitis: standard, problems, and new approaches. Wiener klinische Wochenschrift. 115(3). 10–17. 5 indexed citations
7.
Jendrossek, Verena, Wilfried Kugler, Bernhard Erdlenbruch, H. Eibl, & M. Lakomek. (2001). Induction of differentiation and tetraploidy by long-term treatment of C6 rat glioma cells with erucylphosphocholine. International Journal of Oncology. 19(4). 673–80. 4 indexed citations
8.
9.
Kaufmann‐Kolle, Petra, et al.. (1994). Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine. Cancer Chemotherapy and Pharmacology. 34(5). 393–398. 2 indexed citations
10.
Eibl, H., P. Hilgard, & Christine Unger. (1992). Alkylphosphocholines : new drugs in cancer therapy. OpenGrey (Institut de l'Information Scientifique et Technique). 50 indexed citations
11.
Eibl, H., et al.. (1992). Synthesis of enantiomerically pure lysophosphatidylinositols and alkylphosphoinositols. Chemistry and Physics of Lipids. 60(3). 253–261. 10 indexed citations
12.
Jain, Mahendra Kumar, et al.. (1991). Active-site-directed specific competitive inhibitors of phospholipase A2: novel transition-state analogs. Biochemistry. 30(42). 10256–10268. 93 indexed citations
13.
Rustenbeck, Ingo, H. Eibl, & Sigurd Lenzen. (1991). Structural requirements of lysophospholipid-regulated mitochondrial Ca2+ transport. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1069(1). 99–109. 14 indexed citations
14.
Unger, Clemens, M. Peukert, H. Sindermann, et al.. (1990). Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Cancer Treatment Reviews. 17(2-3). 243–246. 50 indexed citations
15.
Unger, Clemens, H. Eibl, H. W. von Heyden, et al.. (1988). Hexadecylphosphocholine (D 18506) in the Topical Treatment of Skin Metastases: A Phase-I Trial. Oncology Research and Treatment. 11(6). 295–296. 47 indexed citations
16.
Pascher, I., S. Sundell, Karl Harlos, & H. Eibl. (1987). Conformation and packing properties of membrane lipids: The crystal structure of sodium dimyristoylphosphatidylglycerol. Biochimica et Biophysica Acta (BBA) - Biomembranes. 896(1). 77–88. 122 indexed citations
17.
Eibl, H., et al.. (1986). Hexadecylphosphocholine, a new Antineoplastic Agent: Cytotoxic properties in leukaemic cells. Journal of Cancer Research and Clinical Oncology. 111(S1). S24–S24. 8 indexed citations
18.
Harlos, Karl, H. Eibl, I. Pascher, & S. Sundell. (1984). Conformation and packing properties of phosphatidic acid: The crystal structure of monosodium dimyristoylphosphatidate. Chemistry and Physics of Lipids. 34(2). 115–126. 61 indexed citations
19.
Eibl, H., et al.. (1953). [Data on the mode of action of adsorbate vaccine].. PubMed. 138(2). 132–3. 1 indexed citations
20.
Eibl, H., et al.. (1951). Die Wirkung von Toxinen auf Fermente. Monatshefte für Chemie - Chemical Monthly. 82(3). 571–574. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026